3 PHARMACOKINETICS OF ANTI-ARRHYTllllIC AGENTS IN ACUTE

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The pharmacokinetics of disopyramide in patients with acute myocardial infarction.

  1982cited by this paper
• Optimal lidocaine dosing in patients with myocardial infarction.

  1982cited by this paper
• On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.

  1982cited by this paper
• Plasma disopyramide concentrations following a 300-mg oral loading dose in acute myocardial infarction.

  1982cited by this paper
• Disopyramide pharmacokinetics during recovery from myocardial infarction.

  1982cited by this paper
• Relationship between α1‐acid glycoprotein and lidocaine disposition in myocardial infarction

  1981cited by this paper
• Regional myocardial kinetics of lidocaine in experimental infarction: modulation by regional blood flow.

  1981cited by this paper
• Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure

  1981cited by this paper
• Lignocaine and indocyanine green kinetics in patients following myocardial infarction.

  1980cited by this paper
• Procainamide delivery to ischemic canine myocardium following rapid intravenous administration.

  1980cited by this paper
• Lidocaine plasma protein binding

  1980cited by this paper
• Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction.

  1980cited by this paper
• Disease-induced Changes in the Plasma Binding of Basic Drugs

  1980cited by this paper
• Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction

  1980cited by this paper
• Plasma binding of disopyramide.

  1980cited by this paper
• Prophylactic lidocaine in the early management of acute myocardial infarction.

  1980cited by this paper
• Disopyramide kinetics in patients with acute myocardial infarction

  1979cited by this paper
• Pharmacokinetics of digoxin in patients with acute myocardial infarction.

  1979cited by this paper
• Lidocaine kinetics predicted by indocyanine green clearance.

  1978cited by this paper
• Reduction of Enzyme Levels by Propranolol After Acute Myocardial Infarction

  1978cited by this paper
• Procainamide Accumulation Kinetics in the Immediate Postmyocardial Infarction Period

  1978cited by this paper
• Variability of early lidocaine levels in patients.

  1977cited by this paper
• Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.

  1976cited by this paper
• The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.

  1976cited by this paper
• Logical approach to lignocaine therapy.

  1976cited by this paper
• Use of lidocaine by continuous infusion.

  1974cited by this paper
• Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

  1974cited by this paper
• Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.

  1973cited by this paper
• A Study of Ventricular Arrhythmias Associated with Acute Myocardial Infarction in the Canine Heart

  1973cited by this paper
• Primary ventricular fibrillation complicating acute myocardial infarction.

  1971cited by this paper
• Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man

  1971cited by this paper
• Pharmacokinetics of lidocaine in man

  1971cited by this paper

• No citing papers are available for this paper.